Avacta Group plc
Avacta Group plc is a clinical stage biopharmaceutical company focused on drug delivery methods to improve the effectiveness of cancer therapeutics. The company has a research and development facility and a team of scientists and management located in London and the US.
- Affimer drug conjugates
- Rapid diagnostic test kits
- pre|CISION peptide drug conjugates
Locations
Competitors
Creasallis is a biopharmaceutical company focused on innovative antibody therapeutics solutions, particularly in the field of cancer treatment.
Sutura Therapeutics is a biopharmaceutical company dedicated to advancing the field of biomolecular medicine through its peptide-based drug conjugate platform.
Iksuda Therapeutics is dedicated to creating class-leading antibody-drug conjugates (ADCs) with enhanced tumour specificity for hard-to-treat cancers.
Company Details
Avacta Group plc is operated by Avacta Group Plc and is a Active company incorporated on 29 April 2003 with the registered office located in London, Greater London. Avacta Group Plc was registered 22 years ago.
Status
Active
Size
Medium
Directors
13
Age
22 years old
Employees
151
Turnover
Unreported
Total Assets
£48.27M
Cash in Bank
£12.87M
Total Liabilities
-£38.99M